Option Care Health, Inc. (NASDAQ:OPCH) Stake Boosted by Global Alpha Capital Management Ltd.

Global Alpha Capital Management Ltd. boosted its holdings in shares of Option Care Health, Inc. (NASDAQ:OPCH) by 108.3% in the third quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 49,818 shares of the company’s stock after acquiring an additional 25,905 shares during the quarter. Global Alpha Capital Management Ltd.’s holdings in Option Care Health were worth $1,559,000 at the end of the most recent quarter.

Other institutional investors have also made changes to their positions in the company. Blue Trust Inc. increased its position in Option Care Health by 14.8% in the 2nd quarter. Blue Trust Inc. now owns 2,931 shares of the company’s stock worth $81,000 after buying an additional 377 shares during the period. GAMMA Investing LLC boosted its holdings in Option Care Health by 110.6% in the third quarter. GAMMA Investing LLC now owns 897 shares of the company’s stock valued at $28,000 after acquiring an additional 471 shares during the last quarter. Lindenwold Advisors INC boosted its holdings in Option Care Health by 5.4% during the third quarter. Lindenwold Advisors INC now owns 9,548 shares of the company’s stock worth $299,000 after buying an additional 489 shares during the last quarter. Trust Point Inc. raised its position in shares of Option Care Health by 2.6% during the third quarter. Trust Point Inc. now owns 24,124 shares of the company’s stock worth $755,000 after purchasing an additional 622 shares during the period. Finally, Nisa Investment Advisors LLC raised its position in Option Care Health by 5.4% in the 2nd quarter. Nisa Investment Advisors LLC now owns 13,581 shares of the company’s stock valued at $376,000 after buying an additional 690 shares during the last quarter. 98.05% of the stock is currently owned by institutional investors and hedge funds.

Insider Transactions at Option Care Health

In other Option Care Health news, Director Harry M. Jansen Kraemer, Jr. purchased 43,000 shares of the firm’s stock in a transaction that occurred on Friday, November 8th. The stock was bought at an average cost of $22.54 per share, with a total value of $969,220.00. Following the completion of the transaction, the director now owns 326,334 shares of the company’s stock, valued at $7,355,568.36. The trade was a 15.18 % increase in their position. The purchase was disclosed in a legal filing with the SEC, which is accessible through this link. Also, CFO Michael H. Shapiro sold 23,217 shares of the stock in a transaction on Thursday, August 22nd. The shares were sold at an average price of $30.95, for a total value of $718,566.15. Following the transaction, the chief financial officer now directly owns 247,317 shares of the company’s stock, valued at approximately $7,654,461.15. This trade represents a 8.58 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Company insiders own 0.64% of the company’s stock.

Analysts Set New Price Targets

OPCH has been the subject of several recent research reports. JMP Securities boosted their price target on Option Care Health from $36.00 to $37.00 and gave the company a “market outperform” rating in a research note on Monday, September 30th. Barrington Research reduced their price target on Option Care Health from $40.00 to $32.00 and set an “outperform” rating on the stock in a research report on Thursday, October 31st. Jefferies Financial Group lowered Option Care Health from a “buy” rating to a “hold” rating and cut their target price for the company from $38.00 to $26.00 in a research report on Thursday, October 31st. Truist Financial dropped their price target on Option Care Health from $41.00 to $34.00 and set a “buy” rating on the stock in a research note on Friday, November 1st. Finally, The Goldman Sachs Group downgraded Option Care Health from a “buy” rating to a “neutral” rating and dropped their price target for the stock from $38.00 to $27.00 in a research note on Monday, November 4th. Three equities research analysts have rated the stock with a hold rating and three have assigned a buy rating to the stock. According to MarketBeat, Option Care Health has an average rating of “Moderate Buy” and an average price target of $30.83.

Option Care Health Stock Performance

Shares of Option Care Health stock opened at $21.82 on Wednesday. The company has a market cap of $3.71 billion, a PE ratio of 18.34, a price-to-earnings-growth ratio of 2.27 and a beta of 1.32. Option Care Health, Inc. has a 52 week low of $21.39 and a 52 week high of $34.63. The business has a 50 day moving average price of $28.20 and a 200-day moving average price of $29.26. The company has a quick ratio of 1.32, a current ratio of 1.73 and a debt-to-equity ratio of 0.77.

Option Care Health Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.